NZ599554A - ((phenyl)imidazolyl)methylheteroaryl compounds - Google Patents
((phenyl)imidazolyl)methylheteroaryl compoundsInfo
- Publication number
- NZ599554A NZ599554A NZ599554A NZ59955408A NZ599554A NZ 599554 A NZ599554 A NZ 599554A NZ 599554 A NZ599554 A NZ 599554A NZ 59955408 A NZ59955408 A NZ 59955408A NZ 599554 A NZ599554 A NZ 599554A
- Authority
- NZ
- New Zealand
- Prior art keywords
- imidazolyl
- phenyl
- methylheteroaryl
- compounds
- substituents
- Prior art date
Links
- -1 (phenyl)imidazolyl Chemical group 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 230000003466 anti-cipated effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91783307P | 2007-05-14 | 2007-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ599554A true NZ599554A (en) | 2013-12-20 |
Family
ID=39683865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ599554A NZ599554A (en) | 2007-05-14 | 2008-05-13 | ((phenyl)imidazolyl)methylheteroaryl compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100273814A1 (enExample) |
| EP (1) | EP2155715B1 (enExample) |
| JP (1) | JP5323059B2 (enExample) |
| KR (1) | KR20100031502A (enExample) |
| CN (1) | CN101743240B (enExample) |
| AU (1) | AU2008251324B2 (enExample) |
| BR (1) | BRPI0811860A2 (enExample) |
| CA (1) | CA2687303C (enExample) |
| DK (1) | DK2155715T3 (enExample) |
| ES (1) | ES2402746T3 (enExample) |
| IL (1) | IL202137A0 (enExample) |
| MX (1) | MX2009012349A (enExample) |
| NZ (1) | NZ599554A (enExample) |
| RU (1) | RU2478631C2 (enExample) |
| WO (1) | WO2008141312A1 (enExample) |
| ZA (1) | ZA200908088B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009091735A1 (en) * | 2008-01-18 | 2009-07-23 | Allergan.Inc | Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| JP2019517524A (ja) * | 2016-06-02 | 2019-06-24 | パーデュー ファーマ エルピー | 疼痛治療のための微量アミン関連受容体１アゴニスト及び部分アゴニスト |
| WO2024220941A1 (en) * | 2023-04-21 | 2024-10-24 | Alceptor Therapeutics, Inc. | Triaryl agonists of alpha-2 adrenergic receptors |
| WO2024226608A2 (en) * | 2023-04-25 | 2024-10-31 | Aglaeapharma Inc. | Imidazole containing compounds, derivatives therefore, and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098811A (en) * | 1988-09-22 | 1992-03-24 | Minolta Camera Kabushiki Kaisha | Ioner for developing electrostatic latent image comprising specified imidazoles |
| US5750720A (en) * | 1996-03-28 | 1998-05-12 | Ortho Pharmaceutical Corporation | 4- (thien-3-yl)methyl!-imidazole analgesics |
| US6841684B2 (en) * | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
| TWI283669B (en) * | 1999-06-10 | 2007-07-11 | Allergan Inc | Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| BRPI0516025A (pt) * | 2004-09-24 | 2008-08-19 | Allergan Sales Inc | 4-(heteroaril-metil e heteroaril-metil substituìda)-imidazol-2-tionas que atuam como agonistas alfa2 adrenérgicos |
-
2008
- 2008-05-13 DK DK08769462.6T patent/DK2155715T3/da active
- 2008-05-13 JP JP2010508528A patent/JP5323059B2/ja not_active Expired - Fee Related
- 2008-05-13 CN CN2008800220502A patent/CN101743240B/zh not_active Expired - Fee Related
- 2008-05-13 ES ES08769462T patent/ES2402746T3/es active Active
- 2008-05-13 MX MX2009012349A patent/MX2009012349A/es active IP Right Grant
- 2008-05-13 RU RU2009145817/04A patent/RU2478631C2/ru not_active IP Right Cessation
- 2008-05-13 WO PCT/US2008/063489 patent/WO2008141312A1/en not_active Ceased
- 2008-05-13 CA CA2687303A patent/CA2687303C/en not_active Expired - Fee Related
- 2008-05-13 EP EP08769462A patent/EP2155715B1/en not_active Not-in-force
- 2008-05-13 US US12/600,191 patent/US20100273814A1/en not_active Abandoned
- 2008-05-13 KR KR1020097025950A patent/KR20100031502A/ko not_active Ceased
- 2008-05-13 BR BRPI0811860-4A2A patent/BRPI0811860A2/pt not_active IP Right Cessation
- 2008-05-13 AU AU2008251324A patent/AU2008251324B2/en not_active Ceased
- 2008-05-13 NZ NZ599554A patent/NZ599554A/en not_active IP Right Cessation
-
2009
- 2009-11-15 IL IL202137A patent/IL202137A0/en unknown
- 2009-11-17 ZA ZA2009/08088A patent/ZA200908088B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010527369A (ja) | 2010-08-12 |
| CN101743240B (zh) | 2013-07-17 |
| JP5323059B2 (ja) | 2013-10-23 |
| AU2008251324B2 (en) | 2014-05-01 |
| RU2009145817A (ru) | 2011-06-20 |
| WO2008141312A1 (en) | 2008-11-20 |
| AU2008251324A1 (en) | 2008-11-20 |
| CN101743240A (zh) | 2010-06-16 |
| EP2155715A1 (en) | 2010-02-24 |
| DK2155715T3 (da) | 2013-05-13 |
| IL202137A0 (en) | 2010-06-16 |
| BRPI0811860A2 (pt) | 2014-11-18 |
| US20100273814A1 (en) | 2010-10-28 |
| MX2009012349A (es) | 2009-12-01 |
| EP2155715B1 (en) | 2013-03-13 |
| CA2687303A1 (en) | 2008-11-20 |
| KR20100031502A (ko) | 2010-03-22 |
| RU2478631C2 (ru) | 2013-04-10 |
| CA2687303C (en) | 2015-05-05 |
| ES2402746T3 (es) | 2013-05-08 |
| ZA200908088B (en) | 2010-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY145408A (en) | Dihydropyrazolopyrimidinone derivatives | |
| ATE402697T1 (de) | 1,3,5-trisubstituierte 4,5-dihydro-1h-pyrazol- derivative mit cb1-antagonistischer aktivität | |
| BRPI0415185A (pt) | 2h-[1,2,4]triazol[4,3-a]pirazinas substituìdas como inibidores da gsk-3 | |
| MX2010001745A (es) | Imidazoles fusionados para el tratamiento del cancer. | |
| WO2011004162A3 (en) | 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer | |
| PH12014502420B1 (en) | Iap bir domain binding compound | |
| TW200714604A (en) | Substituted heterocycles and the uses thereof | |
| MX2010003612A (es) | Derivados de oxadiazol. | |
| UA95298C2 (ru) | Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств | |
| UA92503C2 (ru) | Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств | |
| SI2150530T1 (sl) | Substituirani sulfonamidni derivati | |
| WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
| NZ613219A (en) | Heterocyclic containing entities, compositions and methods | |
| WO2008036308A3 (en) | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | |
| MX2009013129A (es) | Derivados de indazolamida. | |
| MX2010007026A (es) | Derivados de triazoloxadiazoles. | |
| MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
| WO2003022838A8 (en) | Pyridine substituted furan derivatives as raf kinase inhibitors | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| NZ599554A (en) | ((phenyl)imidazolyl)methylheteroaryl compounds | |
| MXPA04000065A (es) | Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria. | |
| WO2009008345A1 (ja) | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 | |
| TW200505892A (en) | Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use | |
| NZ590076A (en) | Treating plexiform neurofibroma and related tumors | |
| MX2008002753A (es) | Derivados de piridazinona utilizados para el tratamiento de dolor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S23 | Proceedings under section 23: mention of inventor as such in patent |
Free format text: INVENTOR BHAT, SMITA S., CHOW, KEN, GARST, MICHAEL E., HEIDELBAUGH, TODD M., NGUYEN, PHONG X., SINHA, SANTOSH C. ADDED Effective date: 20131121 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 13 MAY 2015 BY AJ PARK Effective date: 20140423 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 MAY 2016 BY COMPUTER PACKAGES INC Effective date: 20150418 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 MAY 2017 BY COMPUTER PACKAGES INC Effective date: 20160419 |
|
| LAPS | Patent lapsed |